Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,264,591 papers from all fields of science
Search
Sign In
Create Free Account
PD 184352
Known as:
PD 184352/CI-1040
, PD-184352
, MEK Inhibitor CI-1040
Expand
An agent that inhibits both mitogen-activated protein kinase kinases 1 and 2 (MEK1 and MEK2), substrates of Raf and phosphorylates extracellular…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CI 1040
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Mitogen-activated Protein Kinases in the Development of Normal and Diseased Kidneys
M. Awazu
2017
Corpus ID: 27397208
Mitogen-activated protein kinases (MAPKs) play important roles in various cellular functions including proliferation…
Expand
2016
2016
Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling.
G. Zhang
,
Margaret A. Park
,
+10 authors
P. Dent
Journal of Biological Chemistry
2016
Corpus ID: 44666908
In Fig. 3A, the image of mouse hepatocytes overexpressing p21 and treated with PD184352 (PD) and deoxycholic acid (DCA) was…
Expand
2016
2016
Correction to: “Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment”
A. Yacoub
,
W. Hawkins
,
+10 authors
P. Dent
Molecular Pharmacology
2016
Corpus ID: 9165275
It has been pointed out to us that the control 0 min time point bands in Figure 2E were duplicated. The control lanes were…
Expand
2014
2014
U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells
T. Smutný
,
Michal Bitman
,
+4 authors
P. Pávek
Archives of Toxicology
2014
Corpus ID: 253714140
Hepatocyte tumor cell lines lack the expression or induction properties of major cytochrome P450 (CYP) enzymes compared to…
Expand
2012
2012
Abstract 4667: Simultaneous Chk1 and MEK1/2 inhibition circumvents Mcl-1 anti-apoptotic function and bortezomib resistance in human multiple myeloma cells
X. Pei
,
Yun Dai
,
+7 authors
S. Grant
2012
Corpus ID: 72628490
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Mcl-1, a critical survival factor for human…
Expand
2009
2009
ERK 5 Expression in Human Prostate Cancer Clinical Significance of Abnormal Extracellular Signal – Regulated Kinase 5 ( ERK 5 ) Expression in Human Prostate Cancer
B. Jenkins
,
R. Heer
,
+4 authors
H. Leung
2009
Corpus ID: 29619357
The MEK5/ERK5 pathway has recently been implicated in prostate and breast carcinogenesis. Over-expression of MEK5 is associat ed…
Expand
2007
2007
Year : 2003 Chronic mild hypoxia protects heart-derived H 9 c 2 cells against acute hypoxia / reoxygenation by regulating expression of the SUR 2 A subunit of the ATP-sensitive K + channel
R. M. Crawford
,
S. Jovanović
,
+7 authors
A. Jovanovic
2007
Corpus ID: 8029738
Chronic exposure to lower oxygen tension may increase cellular resistance to different types of acute metabolic stress. Here, we…
Expand
2007
2007
Influence of PD184352 on the Proliferation and Expression of ERK Protein of Squamous Cell Carcinoma Tca8113
W. Fan
2007
Corpus ID: 87067840
Objective:To observe the influence of PD184352 on the proliferation and expression of ERK protein of squamous cell carcinoma…
Expand
2002
2002
myeloma cells through an IL-6-independent mechanism inhibitors potently induces apoptosis in drug-sensitive and-resistant Combined treatment with the checkpoint abrogator UCN-01 and MEK 1
T. Landowski
,
S. Rosen
,
P. Dent
,
S. Grant
2002
Corpus ID: 14420766
The effects of combined exposure to the checkpoint abrogator UCN-01 and pharmacologic MEK1/2 inhibitors were examined in human…
Expand
2001
2001
ects of MAP kinase cascade inhibitors on the MKK 5 / ERK 5 pathway
Nimesh Modya
,
Jane Leitchb
,
Chris Armstrongb
,
Jack Dixonc
,
P. Cohena
2001
Corpus ID: 52202193
Antibodies that recognise the active phosphorylated forms of mitogen-activated protein kinase (MAPK) kinase 5 (MKK5) and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE